Maria Fardis and Nicola Ambler talk about TILs, mentorship and the importance of partnering
Here's the third Women in Advanced Therapies interview!
This fantastic series highlights a selection of the women featured in the '11 Most Influential Women in Advanced Therapies' report published by Phacilitate earlier this year.
In this episode, Nicola Ambler, Editor at Phacilitate Exchange sits down with biotech CEO Maria Fardis of Iovance, a leader in the race for curing solid tumours with TIL therapy. Maria shares the mentors who have influenced her, the conflicts women must wrestle with when pursuing careers and her ethos when building partnerships in drug development.
Thanks to Maria and Nicola for a great discussion!
Here's the link to the non-dilutive funding eBook too, thanks to our partners Freemind for putting this together with us!
Enjoy, and as always, please share your feedback.
You can also subscribe to the audio-only version, wherever you get your podcasts: